EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

TPS63 - Asthma 8

Sunday 02 Jun, 12:00 PM - 13:00 PM Valencia, Spain
Poster Zone Thematic Poster Session
A case of chronic cough induced by esophageal hypersensitivity
Clinical profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
Efficacy of Dupilumab in patients over 50 years of age with severe asthma
Health Care Situation in the Treatment of Uncontrolled GINA 4/5 Asthma Patients in Germany: 2019 vs. 2022
Insights from Benralizumab Treatment
Lung Function Improvement is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-to-Severe Type 2 Asthma: A Post Hoc Analysis of QUEST
Real-world effectiveness of biologics in patients with severe asthma: analysis of the Korean Severe Asthma Registry (KoSAR)
Respiratory muscle functions in asthma
Stability of steroid-dependent severe asthma during 5-year follow-up
Subcellular Localization and Differential Effects of TSLP Isoforms on Human Lung Macrophages
The Relationship between Mold Sensitivity and Environmental Conditions in Patients Diagnosed with Allergic Rhinitis and Asthma
The dynein adaptor Hook2 as microtubule-based transport and anchors for organelles is involved in asthma pathogenesis
The impact of Type 2- targeted biological therapies on persistent cough in adults with cough variant- or cough predominant asthma
The parasympathetic nervous system plays a key role in control and stress in patients with asthma

Chairs

Speakers